Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - February 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 23 February 2026, 15:00 (CET) to 23 February 2026, 17:00 (CET)

Human medicines European public assessment report (EPAR): Tovanor Breezhaler, glycopyrronium bromide, Date of authorisation: 28/09/2012, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Seebri Breezhaler, glycopyrronium bromide, Date of authorisation: 28/09/2012, Revision: 14, Status: Authorised

Annex to agenda of the CHMP meeting 26-29 January 2026

Agenda of the CHMP meeting 26-29 January 2026

Human medicines European public assessment report (EPAR): Triumeq, abacavir,dolutegravir,lamivudine, Date of authorisation: 31/08/2014, Revision: 39, Status: Authorised

Medical device expert panels

Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - January 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 15 January 2026, 15:00 (CET) to 15 January 2026, 16:00 (CET)

EVVet3 EVWeb Production - Release notes

Agenda - Webinar on the use of platform technologies in the non-clinical and clinical domains